Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Phivida Holdings Inc. PHVAF

Healthcare Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Cannabis
Phivida is a premier brand of cannabidiol ('CBD')-infused functional foods, beverages and clinical products that is poised for global distribution.


OTCQX:PHVAF - Post by User

Phivida Holdings Inc. > Fresh start
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(23)
•••
Comment by status8on Jul 02, 2020 3:00pm
114 Views
Post# 31217242

RE:RE:RE:RE:Fresh start

RE:RE:RE:RE:Fresh startCHOO will clearly leverage what they see as assets, park or shelve what is not of value.

Hopefully, they fund OKI and then sell it off.

Of just keep it, grow CHOO and hope that the next merger also has OKI as an arm of the 'new' company.

VIDA is a huge premium right now. 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities